The 4th IMSUT-CGCT Symposium 2017
Date: Tuesday June 27, 2017
Venue: IMSUT Hospital, 8F (Tomy Hall)
Moderator: Sumimasa Nagai (IMSUT)

Opening Remarks_
9:30~9:40

Yoshinori Murakami
Dean, The Institute of Medical Science, The University of Tokyo (IMSUT)

Introduction_
9:40~10:00

Keiya Ozawa
Director, Center for Gene & Cell Therapy (CGCT), IMSUT****************************************************************

Chairperson: Toshio Kitamura (IMSUT)
10:00~10:30

Development of innovative DNA-based medicine for diabetic peripheral neuropathy:
Scientific basis and results of phase II studies in the US
Sunyoung Kim
School of Biological Sciences, Seoul National University / ViroMed, Co Ltd., Korea

10:30~11:00

Adeno-associated virus (AAV)-based gene therapy
Shin-ichi Muramatsu
Division of Neurology, Jichi Medical University
Center for Gene & Cell Therapy (CGCT), IMSUT

Chairperson: Jeongbin Yim (SIMS/SNU, A-IMBN, Korea)
11:00~11:30

Antisense oligonucleotide (ASO) therapy, Nusinersen, for spinal muscular atrophy (SMA)
Shinichi Torii
Biogen Japan Ltd.

11:30~12:00

Application of human pluripotent stem cells for neurodegenerative disease modeling study
Jae-won Shim
Soonchunhyang Institute of Medi-bio Science (SIMS), Soonchunhyang University, Korea

12:00~13:00

Lunch Time

Chairperson: Kenzaburo Tani (IMSUT)
13:00~13:30

Modeling of retinal degeneration and its application to develop therapeutic strategy
Sumiko Watanabe
Division of Molecular and Developmental Biology, IMSUT

13:30~14:00

Clinical development of oncolytic HSV-1 armed with IL-12
Ryuhei Okuyama
Department of Dermatology, Shinshu University School of Medicine

Chairperson: Maoyen Chi (CSHL Asia, China)
14:00~14:30

25 Years after the discovery of JAK-STAT pathway: A “PeriGenetic” model for cancer,
inflammation and precision medicine
Xin-Yuan Fu
Cancer Science Institute of Singapore, National University of Singapore, Singapore

14:30~15:00

CAR (chimeric antigen receptor)-T cell therapy for solid tumors
Koji Tamada
Yamaguchi University Graduate School of Medicine
Center for Gene & Cell Therapy (CGCT), IMSUT
Coffee Break

15:00~15:30

Chairperson: Tomoki Todo (IMSUT)
15:30~16:00

Characteristics and clinical applications of umbilical cord-derived mesenchymal stromal cells
Tokiko Nagamura-Inoue
Department of Cell Processing and Transfusion / IMSUT CORD, IMSUT

16:00~16:30

Adipose-derived mesenchymal stem cells: Potential for metabolic reprogramming
Shigeki Sugii
Singapore Bioimaging Consortium, A*STAR / Duke-NUS Medical School, Singapore
16:30~17:00

Clinical sequencing in hematological malignancies with AI assistanceArinobu Tojo
Division of Molecular Therapy, Advanced Clinical Research Center, IMSUT****************************************************************

Concluding Remarks_
17:00~17:15

Ken-ichi Arai
Health & Medicine Paradigm Shift Consortium (HMPSC) / Asia-pacific International
Molecular Biology Network (A-IMBN) / IMSUT / SBI Biotech

17:45~19:00

Reception/Dinner at IMSUT Medical Science Museum (Invitation-only)

Organized by IMSUT-CGCT
Supported by HMPSC, A-IMBN, BIOGEN, BIOtech2017【Secretariat】
Division of Genetic Therapeutics, Advanced Clinical Research Center, IMSUT
4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, JAPANTEL: +81-3-5449-5580
FAX: +81-3-5449-5443